Search Website
The Cooperative Trials Group for Neuro-Oncology (COGNO) was established in 2007, following identification of a need to develop a central mechanism enabling a coordinated, structured approach to the management of large scale multi-centred neuro-oncology trials.
COGNO is a member of the Cooperative Clinical Trials Groups of the Clinical Oncological Society of Australia (COSA) and has a close working relationship with the COSA Neuro-Oncology Group. COGNO is funded by Cancer Australia. The group is located at the National Health and Medical Research Council (NHMRC) Clinical Trials Centre (CTC), at the University of Sydney. The NHMRC CTC coordinates the trials activity within COGNO.
COGNO's main aim is to conduct investigator-initiated and collaborative group trials addressing important clinical questions in patients with brain tumours.
Interview with COGNO's 800th Member 
COGNO has reached an important milestone, celebrating its 800th member! To mark this special occasion, COGNO Chair Associate Professor Eng-Siew Koh, has a "Q&A" session with Dr Peter Lau, Medical Oncologist from Sir Charles Gairdner Hospital, WA.
Watch the 10 minute interview here.
Brain cancer patients are in desperate need of major research breakthroughs, yet brain cancer remains one of the most underfunded and under researched of all the cancer groups.
Your donation will help COGNO bring clinical trials to more people with brain cancer.  Online donations can be made via https://www.braincancercollective.com.au/donations_cogno

BCC Bike Ride for Brain Cancer Fundraiser: 19-20 March 2021
Congratulations to the Brain Cancer Collective for a successful bike ride. BCC held their third 2 day fundraising Bike Ride for Brain Cancer – 240km from Sydney to the Hunter Valley -  19 and 20 March 2021. The date coincides with the birthday of Lucie Leonard, who died from brain cancer in 2012, and is the inspiration for the establishment of BCC. For further information visit https://www.bikerideforbraincancer.com.au/.

Ideas or Concepts

COGNO is interested in developing new concepts into protocols and translating these into clinical research.

If you have a concept you are interested in developing, please complete this online form.

Recent News

12/01/2022: COGNO: MRFF grant success - the LUMOS2 study

Congratulations to the lead investigator Professor Hui Gan and the co-investigator team for their recent grant success in being awarded $1.98 million for the LUMOS2 (Low and Anaplastic Grade Glioma Umbrella Study of Molecular Guided TherapieS) study, announced this week under the MRFF 2021 Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) grant opportunity.

10/08/2021: COGNO Newsletter Issue 37 now available

Issue 37 of the COGNO Member Newsletter (Winter 2021 Edition) is now available for download from the COGNO Newsletters page.

1/04/2021: COGNO Newsletter Issue 36 now available

Issue 36 of the COGNO Member Newsletter (Autumn 2021 Edition) is now available for download from the COGNO Newsletters page.